Insmed
INSM
#542
Rank
C$60.10 B
Marketcap
C$281.83
Share price
-0.51%
Change (1 day)
166.82%
Change (1 year)

Insmed (INSM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$1.95 Billion

According to Insmed's latest financial reports the company's total liabilities are C$1.95 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insmed - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$2.49 B13.27%
2023-12-31C$2.20 B3.56%
2022-12-31C$2.12 B100.47%
2021-12-31C$1.06 B60.04%
2020-12-31C$0.66 B5.68%
2019-12-31C$0.62 B16.28%
2018-12-31C$0.53 B325.17%
2017-12-31C$0.12 B13.19%
2016-12-31C$0.11 B80.27%
2015-12-31C$62.22 M20.16%
2014-12-31C$51.78 M46.65%
2013-12-31C$35.31 M8.67%
2012-12-31C$32.49 M473.96%
2011-12-31C$5.66 M65.52%
2010-12-31C$3.42 M16.9%
2009-12-31C$2.92 M-68.26%
2008-12-31C$9.21 M15.33%
2007-12-31C$7.99 M-52.55%
2006-12-31C$16.84 M17.24%
2005-12-31C$14.36 M107.1%
2004-12-31C$6.93 M48.89%
2003-12-31C$4.65 M-39.3%
2002-12-31C$7.67 M-59.55%
2001-12-31C$18.97 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
C$3.00 B 53.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$86.39 B 4,319.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
C$51.22 B 2,519.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
C$1.66 B-14.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.74 B-61.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$10.42 B 433.05%๐Ÿ‡บ๐Ÿ‡ธ USA